Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 109
References Calver, A. D., A. A. Falmer, M. Murray, O. J. Strauss, E. M. Streicher, M. Hanekom, T. Liversage, M. Masibi, P. D. van Helden, R. M. Warren, and T. C. Victor. 2010. Emer- gence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerging Infectious Diseases 16(2):264-271. Chen, M. 2010. MDR-TB Control and Prevention in China. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation. Dimitrova, B., A. Hutchings, R. Atun, F. Drobniewski, G. Marchenko, S. Zakharova, I. Fedorin, and R. J. Coker. 2005. Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: Analysis of notification data. International Journal of Tuber- culosis and Lung Disease 9(1):43-48. Frolova, O. 2010. Drug-Resistant Tuberculosis in HIV Patients. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation. Gelmanova, I. Y., S. Keshavjee, V. T. Golubchikova, V. I. Berezina, A. K. Strelis, G. V. Yanova, S. Atwood, and M. Murray. 2007. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: Non-adherence, default and the acquisition of multidrug resistance. Bulletin of the World Health Organization 85(9):703-711. Global Alliance for TB Drug Development. 2010. TB Alliance portfolio. http://www.tballiance. org/downloads/mediakit/TBA_Portfolio_%202.4.2011.pdf (accessed February 14, 2011). Golubchikov, P., S. Mishustin, and G. Yanova. 2010. MDR Tuberculosis in People with Drug and Alcohol Dependencies: Tomsk Oblast. Speaker presentation at the Institute of Medi- cine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation. Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. Journal of Clinical Microbiology 45(5):1483-1490. 109
OCR for page 110
110 DRUG-RESISTANT TUBERCULOSIS IN RUSSIA Hoek, K G., H. S. Schaaf, N. C. Gey van Pittius, P. D. van Helden, and R. M. Warren. 2009. Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. South African Medical Journal 99(11):785-787. IOM (Institute of Medicine). 2009. Addressing the threat of drug-resistant tuberculosis: A realistic assessment of the challenge: Workshop summary. Washington, DC: The National Academies Press. IOM. 2011. The emerging threat of drug-resistant tuberculosis in Southern Africa: Global and local challenges and solutions: Workshop summary. Washington, DC: The National Academies Press. Johnson, R., A. M. Jordaan, L. Pretorius, E. Engelke, G. van der Spuy, C. Kewley, M. Bosman, P. D. van Helden, R. Warren, and T. C. Victor. 2006. Ethambutol resistance testing by mutation detection. International Journal of Tuberculosis and Lung Disease 10(1):68-73. Keshavjee, S., and K. Seung. 2008. Stemming the tide of multidrug-resistant tuberculo- sis: Major barriers to addressing the growing epidemic. http://www.iom.edu/~/media/ Files/Activity%20Files/Research/DrugForum/IOM_MDRTB_whitepaper_2009_01_14_ FINAL_Edited.pdf (accessed August 30, 2010). Kuzmin, A. V., I. A. Vasileva, and L. N. Chernousova. 2006. Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the “TB-Biochip” test system. Probl Tuberk Bolezn Legk (8):17-23. Li, R. 2010. Surveillance for Anti-Tuberculosis Drug Resistance in China. Speaker presen- tation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation. Llerena, C., S. E. Fadul, M. C. Garzón, G. Mejía, D. L. Orjuela, L. M. García, H. B. Álvarez, and F. J. Ruiz. 2010. Drug-resistant Mycobacterium tuberculosis in children under 15 years. Biomedica 30(3):362-370. Louw, G. E., R. M. Warren, P. R. Donald, M. B. Murray, M. Bosman, P. D. Van Helden, D. B. Young, and T. C. Victor. 2006. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. International Journal of Tuberculosis and Lung Disease 10(7):802-807. Mlambo, C. K., R. M. Warren, X. Poswa, T. C. Victor, A. G. Duse, and E. Marais. 2008. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. International Journal of Tuberculosis and Lung Disease 12(1):99-104. Morozova, T. I. 2008 (unpublished). Experience of MDR TB treatment in Saratov region. Presented at 1st Scientific Practical Conference “Problems of diagnostics and treatment of MDR and XDR tuberculosis,” Central Institute for Tuberculosis, Russian Academy of Medical Sciences, December 18-19, 2008. Mphahlele, M., H. Syre, H. Valvatne, R. Stavrum, T. Mannsåker, T. Muthivhi, K. Weyer, P. B. Fourie, and H. M. Grewal. 2008. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiol- ogy 46(10):3459-3464. Nardell, E., B. McGinnis, B. Thomas, and S. Weidhaas. 1986. Exogenous reinfection with tuberculosis in a shelter for the homeless. New England Journal of Medicine 315:1570-1575. Nugent, R., E. Back, and A. Beith. 2010. The race against drug resistance: A report of the Center for Global Development’s Drug Resistance Working Group. http://www.cgdev. org/content/publications/detail/1424207/ (accessed August 19, 2010). Perelman, M. I. 2000. Tuberculosis in Russia. International Journal of Tuberculosis and Lung Disease 4(12):1097-1103. PIH (Partners In Health). 2010. Socios En Salud project history. http://www.pih.org/pages/ peru-history# (accessed August 31, 2010).
OCR for page 111
111 REFERENCES Safonova, S. 2010. Epidemiological Indicators for Tuberculosis in Russia’s Penal Institutions (2000-2009). Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Mos- cow, Russian Federation. Skachkova, E. 2010. The Russian Federation’s National MDR TB Surveillance System. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation. Streicher, E. M., R. M. Warren, C. Kewley, J. Simpson, N. Rastogi, C. Sola, G. D. van der Spuy, P. D. van Helden, and T. C. Victor. 2004. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. Journal of Clinical Microbiology 42(2):891-894. van der Spuy, G. D., K. Kremer, S. L. Ndabambi, N. Beyers, R. Dunbar, B. J. Marais, P. D. van Helden, and R. M. Warren. 2009. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinburgh, Scotland) 89(2):120-125. WHO (World Health Organization). 1996. Groups at risk: WHO report on the tuberculosis epidemic. Geneva, Switzerland: WHO. WHO. 2006. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland: WHO. WHO. 2008. Anti-tuberculosis drug resistance in the world, report no. 4: The World Health Organization (WHO)/International Union Against Tuberculosis and Lung Disease (IUATLD) Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002- 2007. Geneva, Switzerland: WHO. WHO. 2009. Global tuberculosis control: Epidemiology, strategy, financing. Geneva, Swit- zerland: WHO. WHO. 2010a. 2010/2011 tuberculosis global facts. http://www.who.int/tb/publications/2010/ factsheet_tb_2010.pdf (accessed February 8, 2011). WHO. 2010b. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global Re- port on Surveillance and Response. Geneva, Switzerland: WHO. http://whqlibdoc.who. int/publications/2010/9789241599191_eng.pdf (accessed August 18, 2010). WHO. 2010c. Global tuberculosis control: WHO Report 2010. Annex 2: Global, regional and country-specific data for key indicators. Geneva, Switzerland: WHO. WHO. 2010d. Factsheet: Tuberculosis diagnostics automated DNA test. http://www.who.int/ tb/features_archive/new_rapid_test/en/index.html (accessed December 29, 2010). Willingham F. F., T. L. Schmitz, M. Contreras, S. E. Kalangi, A. M. Vivar, L. Caviedes, E. Schiantarelli, P. M. Neumann, C. Bern, and R. H. Gilman. 2001. Working Group on TB in Peru. Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerging Infectious Diseases 7(1):123-127. Wright, A., M. Zignol, A. Van Deun, D. Falzon, S. R. Gerdes, K. Feldman, S. Hoffner, F. Drobniewski, L. Barrera, D. van Soolingen, F. Boulabhal, C. N. Paramasivan, K. M. Kam, S. Mitarai, P. Nunn, M. Raviglione, and Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2009. Epidemiology of antituberculosis drug resistance 2002-07: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveil- lance. Lancet 373(9678):1861-1873. Yakimova, M. 2010. The Epidemiology of Tuberculosis in Russia. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.
OCR for page 112